Home » Topics » BioWorld Science

BioWorld Science
RSS

Alpha Cognition reports preclinical data from ALPHA-1062 intranasal TBI program

Dec. 7, 2021

Spago completes regulatory preclinical program with Tumorad

Dec. 7, 2021

Kaleido and Janssen expand Microbiome Metabolic Therapies collaboration

Dec. 7, 2021

Gb Sciences develops cannabinoid-containing complex mixtures to target CRS in COVID-19

Dec. 7, 2021

Gritstone and CEPI expand agreement for SAM vaccine to target SARS-CoV-2 Omicron variant

Dec. 7, 2021

Phylex develops SARS-CoV-2 vaccine targeting Delta and Omicron variants

Dec. 7, 2021

Incyte describes new mutant GTPase KRAS inhibitors

Dec. 7, 2021

Jiangsu Simcere Pharmaceutical R&D discovers SERDs

Dec. 7, 2021

New ACSS2 inhibitors discovered at Metabomed

Dec. 7, 2021

Shanghai Litedd presents new nuclear receptor RORgammaT antagonists

Dec. 7, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...